Abstract: The present invention provides nucleic acid molecules encoding a 30kDa TNF inhibitor or a fragment thereof having at least one non-native cysteine residue at the N-terminus, C-terminus, residue 14, or residue 15.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
April 1, 2003
Assignee:
Angen Inc.
Inventors:
Michael T. Brewer, Robert C. Thompson, Tadahiko Kohno